MedCity News

Novartis Continues RNA & Neuroscience Growth Strategy With $12B Avidity Bio Acquisition

How Hospitals Are Keeping Up with the Rapid Rise of AI

At MedCity News’ Tête-à-tête Health event, executives from Sutter Health and Tampa General Hospital discussed how they are deploying AI, as well as how they are keeping governance and the human touch at the forefront.

By Katie Adams

Health Tech

Why the Women’s Health Space Needs to Expand Beyond Reproductive Health

Health tech company Visana is urging the women’s health industry to expand its focus beyond reproductive care to address broader issues like cardiometabolic health, obesity and hormonal conditions that affect the majority of women outside the family-building years.

By Marissa Plescia

BioPharma, Pharma

Bayer Menopause Drug Lands FDA Approval, Bringing Competition to an Astellas Product

Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to temperature regulation. The once-daily pill came from Bayer’s 2020 acquisition of KaNDy Therapeutics.

By Frank Vinluan

Latest Video

Latest News

MedCity Influencers

Innovations Offer Hope in the Fight Against Antibiotic Resistance

Antibiotic resistance is a growing global threat with serious health and economic consequences. Yet there is progress – from rapid PCR diagnostics and AI-driven research to new drug development and innovative funding models.

By Greer Massey

MedCity Influencers

Phony Bank Account Change Requests: A Growing Threat for Healthcare Finance Leaders

Phony bank account change requests aren’t just another check box on a fraud prevention list – they’re one of the most immediate and dangerous threats facing healthcare AP teams today.

By Phil Binkow

Health Tech

How the Stigma Around Male Infertility Can Be Reduced

At the HLTH conference in Las Vegas, Colton Underwood and fertility experts highlighted the need to break the stigma around male infertility, urging greater awareness, testing and support to recognize it as a men’s health issue as much as a women’s one.

By Marissa Plescia

Health Tech, Startups, Artificial Intelligence

Digitally generated image of rolling coins that follow a set path. The concept of finance, fintech technology, new banking, investment.

Inside Town Hall Ventures’ New $440M Fund

Town Hall Ventures launched its fourth fund, targeting $440 million to back startups using AI to improve healthcare access and outcomes for underserved populations.

By Katie Adams

BioPharma, Startups

Startup Expedition Medicines Launches to Learn Nature’s Rules for Binding Elusive Proteins

Flagship Pioneering’s newest startup is Expedition Medicines, a company whose artificial intelligence-driven technology platform analyzes the human proteome to learn the chemistry of binding small molecules to protein targets long considered “undruggable.” Expedition already has a cancer drug R&D alliance with Pfizer.

By Frank Vinluan

MedCity Influencers

Stethoscope with leather work gloves and corn. Rural healthcare, farmer mental health and farm worker health and safety concept rural health

Rural Health Transformation Program: What States and Counties Need to Know to Optimize New Funding

With closures accelerating and communities already losing access to care, the countdown to FY 2026 is not far off. States, providers and technology partners that act now will define the future of rural health for decades; those that delay may leave billions untapped and lives at risk.

By Vatsala Kapur

MedCity Influencers

Redefining Clinical Oncology Trials: How Agile Site Networks Accelerate Novel Cancer Therapies

Site networks can play a pivotal role in aligning sponsors, sites, and investigators toward shared goals in oncology clinical trials, but they are not one-size-fits-all. Sponsors must carefully vet site networks to validate that they will deliver strategic value for each individual study.

By Matt Cooper and Scott Palmese

Opinion

Big Bets, Long Bets: Investing in the Power of Ideas

With science funding catapulted into the cultural conversation more than ever in the last year, it faces a critical inflection point. There is an opportunity to design a path forward that builds stability in the short term and opens doors in the long term for foundational and transformational science and technology solutions that will benefit our planet and its people.

By Lynda Stuart

Health Tech

Insight Timer Unveils Free Therapist Hub to Support Mental Health Professionals and Ease Burnout

Insight Timer launched the Therapist Hub, a free platform offering resources to help mental health professionals combat burnout and better support clients.

By Marissa Plescia

Artificial Intelligence, Startups, Health Tech, Providers

INVEST Pitch Perfect Spotlight: How Docology Is Automating a Broken Step in Patient Referrals

Docology is tackling inefficiencies in the patient referral process by using AI to automate and summarize medical records. The company recently won MedCity News’ INVEST Digital Health startup pitch competition, highlighting its potential to fill a critical gap in clinical workflows.

By Katie Adams

BioPharma, Pharma

GSK Blood Cancer Drug Returns to the U.S. Market, But New FDA Approval Is Still Limited

GSK drug Blenrep, which exited the market in 2022 after failing a confirmatory study, now has a new FDA approval as a third-line multiple myeloma treatment. The U.S. regulatory decision is more limited than the recent European approval for the blood cancer drug.

By Frank Vinluan

California’s Top Revision Facelift Surgeons: Achieving Optimal Results

California’s leading facial plastic surgeons redefine revision facelifts through precision, innovation and patient-centered artistry. Find out which ones get the best results.

By L&P Aesthetics

MedCity Influencers

Large blue dollar sign resting on a pink surface, surrounded by white arrows pointing in various directions, with a prominent red arrow directing attention toward the dollar sign healthcare opportunity

A New Era for Cell and Gene Therapy Signals New Market Opportunities

Recent developments, including a high-profile acquisition and key regulatory changes, point to a paradigm shift. Cell and gene therapy is becoming increasingly commercially viable, with the potential to improve the lives of millions.

By Ed Ahn